sAbsolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19

Absolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19

Our portfolio makes money.

Since 2018, we've beaten the market with a smart mix of crypto and common stocks. Here's how.

Comments are closed.